TrumpRx promised a supermarket for cheaper drugs but delivered a boutique

Trump's grand promise of TrumpRx as a game-changer in affordable healthcare fell short, according to an NPR investigation that uncovered limited deals on just a handful of drugs from major pharmaceutical companies. While Trump hailed it as the biggest healthcare innovation in decades, critics argue that the initiative's actual impact on drug affordability is minimal. This situation highlights ongoing frustrations with the pharmaceutical industry's pricing practices and raises questions about the effectiveness of presidential initiatives in addressing healthcare costs.